Old Dominion University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Norfolk VA United States (1930)

Organization Overview

First Clinical Trial
2006
NCT00283504
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Childrens Hospital of the King's Daughters | Children's Hospital of The King's Daughters | Old Dominion University

Active Ingredients

Drugs in Phase 4 Trials (2)

omalizumab (xolair) (1 trial)

zolmitriptan (zomig) (1 trial)

Drugs in Phase 3 Trials (3)

hydroxyurea (hydrea) (1 trial)

naproxen (naprosyn) (1 trial)

pregabalin (lyrica) (1 trial)

Drugs in Phase 2 Trials (2)

cannabidiol (Epidiolex) (1 trial)

oxygen (1 trial)

Drugs in Other Trials (1)

ginger (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aggression (Phase 2)

Alzheimer Disease (Phase 2)

Anemia (Phase 3)

Anemia, Sickle Cell (Phase 3)

Asthma (Phase 4)

Dementia (Phase 2)

Diabetic Neuropathies (Phase 3)

Headache (Phase 4)

Migraine Disorders (Phase 4)

Neuralgia (Phase 3)

Neurocognitive Disorders (Phase 2)

Peripheral Nervous System Diseases (Phase 3)

Psychomotor Agitation (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 8